Andrew Slutsky - Net Worth and Insider Trading

Andrew Slutsky Net Worth

The estimated net worth of Andrew Slutsky is at least $22 Million dollars as of 2024-04-26. Andrew Slutsky is the President, Consumer of GoodRx Holdings Inc and owns about 3,081,947 shares of GoodRx Holdings Inc (GDRX) stock worth over $22 Million. Details can be seen in Andrew Slutsky's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Andrew Slutsky has not made any transactions after 2022-01-03 and currently still holds the listed stock(s).

Transaction Summary of Andrew Slutsky

To

Andrew Slutsky Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Andrew Slutsky owns 1 companies in total, including GoodRx Holdings Inc (GDRX) .

Click here to see the complete history of Andrew Slutsky’s form 4 insider trades.

Insider Ownership Summary of Andrew Slutsky

Ticker Comapny Transaction Date Type of Owner
GDRX GoodRx Holdings Inc 2022-01-03 President & Consumer

Andrew Slutsky Latest Holdings Summary

Andrew Slutsky currently owns a total of 1 stock. Andrew Slutsky owns 3,081,947 shares of GoodRx Holdings Inc (GDRX) as of January 3, 2022, with a value of $22 Million.

Latest Holdings of Andrew Slutsky

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
GDRX GoodRx Holdings Inc 2022-01-03 3,081,947 7.08 21,820,185

Holding Weightings of Andrew Slutsky


Andrew Slutsky Form 4 Trading Tracker

According to the SEC Form 4 filings, Andrew Slutsky has made a total of 14 transactions in GoodRx Holdings Inc (GDRX) over the past 5 years, including 0 buys and 14 sells. The most-recent trade in GoodRx Holdings Inc is the sale of 35,829 shares on January 3, 2022, which brought Andrew Slutsky around $1 Million.

Insider Trading History of Andrew Slutsky

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Andrew Slutsky Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Andrew Slutsky Ownership Network

Ownership Network List of Andrew Slutsky

No Data

Ownership Network Relation of Andrew Slutsky


Andrew Slutsky Owned Company Details

What does GoodRx Holdings Inc do?

Who are the key executives at GoodRx Holdings Inc?

Andrew Slutsky is the President & Consumer of GoodRx Holdings Inc. Other key executives at GoodRx Holdings Inc include Interim Chief Executive Office Scott Wagner , Chief Operating Officer Raj Beri , and Chief Accounting Officer Romin Nabiey .

GoodRx Holdings Inc (GDRX) Insider Trades Summary

Over the past 18 months, Andrew Slutsky made no insider transaction in GoodRx Holdings Inc (GDRX). Other recent insider transactions involving GoodRx Holdings Inc (GDRX) include a net purchase of 182,900 shares made by Scott Wagner ,

In summary, during the past 3 months, insiders sold 0 shares of GoodRx Holdings Inc (GDRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of GoodRx Holdings Inc (GDRX) were sold and 182,900 shares were bought by its insiders, resulting in a net purchase of 182,900 shares.

GoodRx Holdings Inc (GDRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

GoodRx Holdings Inc Insider Transactions

No Available Data

Andrew Slutsky Mailing Address

Above is the net worth, insider trading, and ownership report for Andrew Slutsky. You might contact Andrew Slutsky via mailing address: 233 Wilshire Road, Santa Monica Ca 90410.

Discussions on Andrew Slutsky

No discussions yet.